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Abstract: An 8-year-old alpaca was admitted to the emergency service of the Clinic for Ruminants
in Bern due to a reduced general condition and progressive neurological signs. Despite supportive
treatment, its condition deteriorated and the animal had to be euthanized. Histopathological analysis
revealed a severe non-suppurative polioencephalomyelitis with neuronal necrosis, most likely of
viral origin. We detected abundant neuronal labelling with antibodies directed against two different
epitopes of Bovine Astrovirus CH13/NeuroS1 (BoAstV-CH13/NeuroS1), which is a common viral
agent associated with non-suppurative encephalitis in Swiss cattle. These findings were further
verified by detection of viral RNA by use of in-situ hybridization and real-time RT-PCR. Next
generation sequencing revealed that the detected virus genome had a pairwise identity of 98.9% to
the genome of BoAstV-CH13/NeuroS1. To our knowledge, this is the first report of an astrovirus-
associated polioencephalomyelitis in an alpaca. These results point to the possibility of an interspecies
transmission of BoAstV-CH13/NeuroS1.
Keywords: astrovirus; polioencephalomyelitis; alpaca; immunohistochemistry; real-time RT-PCR;
next generation sequencing
1. Introduction
Astroviruses are small, non-enveloped viruses with a non-segmented, single-stranded
positive-sense RNA genome which were first identified in 1975 in stool samples of children
suffering from diarrhea [1,2]. Since then, they have been found worldwide in humans,
especially in infants and children, suffering from gastroenteritis, and are among the most
common pathogens to cause juvenile diarrhea [1–4]. In recent years, several studies have
identified astrovirus-associated CNS infections in humans, mink, cattle, sheep, pigs, and a
muskox [1,2,5–16]. Remarkably, the majority of these neurotropic astroviruses phylogeneti-
cally cluster together in the so-called human–mink–ovine (HMO) clade, in which various
enterotropic strains are also included [7,8]. Human cases of astrovirus-associated encephali-
tis are rare and usually associated with immunosuppression, and a systemic spread of the
initial enteric infection with subsequent affection of the CNS has been discussed in these
patients [1,2,9]. However, more precise mechanisms of neurologic involvement of these
viruses still remain unknown.
In cattle, viruses of two distinct genotype species belonging to the HMO clade
have been identified in cases of encephalitis, Bovine Astrovirus CH13/NeuroS1 (BoAstV-
CH13/NeuroS1) and Bovine Astrovirus CH15 (BoAstV-CH15) [12,17]. To this day, cases of
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BoAstV-CH13/NeuroS1-associated encephalitis in cattle have been reported in Switzer-
land, the USA, Canada, Uruguay, Italy, Japan, and the UK [5,11–13,18–20]. In Switzerland,
BoAstV-CH13/NeuroS1 was detected in up to 34% of cattle with non-suppurative en-
cephalitis and is therefore considered an important etiology for viral encephalitis in this
species [11]. Up to now, cases of BoAstV-CH13/NeuroS1 appeared to be restricted to cattle.
In contrast to BoAstV-CH13/NeuroS1, the strain BoAstV-CH15 was not only identified
in cattle, but a virus almost identical to BoAstV-CH15 was detected in several sheep with
neurological disease [16,21]. These findings and other phylogenetic studies suggest that
certain astroviruses are not host specific and potentially cross species barriers [2,5,6,15,16].
Here, we describe the detection of a neurotropic astrovirus in the central nervous system
(CNS) of a neurologically diseased alpaca in Switzerland, which to our knowledge, is the
first described case of astrovirus infection in this species.
Case
In May 2019, an 8-year-old, 84 kg, domestic huacaya alpaca mare was referred to the
Clinic for Ruminants at the Vetsuisse-Faculty, University of Bern, because of a reduced
general condition, anorexia, trembling, and signs of colic on-going for two days. The day
before referral to the clinic, the animal was treated with spasmolytics by the private vet-
erinarian; however, without improvement of the animal’s condition. The alpaca lived in
a group with four other alpacas, which were all considered healthy showing no clinical
signs. At admission, the alpaca was in a good body condition, but apathetic and standing
in a sawhorse stance. A thorough clinical examination revealed reduced gastrointestinal
peristalsis and uncoordinated and stiff movements, particularly affecting the hind limbs,
with occasional dragging of the toes, and falling to the ground (video sequence of gait
abnormalities submitted as Supplementary Materials). The menace response was absent
on the left eye, and from time to time the animal showed tremor. A complete blood cell
count and blood chemistry were performed and values were as follows: hematology and
blood gas analysis were within normal range, biochemistry showed mild hypomagne-
semia (0.89 mmol/L, reference 0.90–1.19 mmol/L), hypophosphatemia (1.16 mmol/L,
reference 1.39–2.68 mmol/L), elevated creatine kinase (1065 IU, reference 37–108 IU), hy-
perbilirubinemia (1.8 µmol/L, reference 0–1.7 µmol/L), and mildly increased levels of
gamma-glutamyltransferase (35 IU, reference 11–33 IU). The animal was hospitalized,
treated with antibiotics (benzylpenicillin, Penicillin-Natrium Streuli, 30,000 IU/kg, iv,
Streuli pharma), non-steroidal anti-inflammatory drugs (ketoprofen, Dolovet, 3 mg/kg,
iv, Dr. E. Graeub AG), vitamin B supplements (vitamin B1/B6/B12, B-Neuron, 5 mL, sc,
Vetoquinol AG), tocopherol (Tocoselenit; 5 mg/kg, sc, Dr. E. Graeub AG), and sodium
selenite (Selen-E Vetag, 0.2 mg/kg, sc, MSD animal health GmbH), and rehydrated with
sodium-chloride infusions. Clinical exams were performed daily. Over the next three days,
the general condition of the alpaca further deteriorated and neurological signs worsened.
The animal developed severe proprioceptive deficits, muscle tremor, had difficulties stand-
ing up, and showed compulsive movements to the left. A space-occupying mass within
the CNS was suspected. Due to the progression of neurological signs and lack of response
to treatment, the owner requested euthanasia of the animal due to the poor prognosis.
The animal was euthanized with an intravenous injection of pentobarbital (Esconarkon
ad us. vet., 150 mg/kg, iv, Streuli Pharma AG) and was subsequently submitted to the
Institute of Animal Pathology at the Vetsuisse-Faculty, University of Bern for a post-mortem
examination.
2. Materials and Methods
2.1. Samples
A full post-mortem examination of the submitted carcass was performed. After gross
examination, tissue samples from the brain (medulla oblongata, cerebellum, midbrain, hip-
pocampus, cerebral cortex), spinal cord (cervical, thoracic, lumbar, and sacral spinal cord),
heart, liver, uterus, and kidney were collected and placed in 4% formalin. The following
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day, formalin-fixed tissues were trimmed, embedded in paraffin, and hematoxylin and
eosin (HE) stained histological tissue sections were prepared. Slides were then assessed







Figure 1. (a–d): Histopathological changes in the medulla oblongata (a,b) and the spinal ganglia (c,d)
of the diseased alpaca, hematoxylin and eosin stain. (a): Note the presence of multifocal prominent
perivascular cuffs (arrows), bar 2 mm. (b): Perivascular cuffs consist predominantly of lymphocytes
(black arrow heads), bar 100 µm. (c): Lymphocytes also infiltrate the spinal ganglia (asterisk),
bar 500 µm. (d): Some neurons are shrunken and pale (black arrow) or display hypereosinophilia
with pyknosis and chromatolysis (white arrow) (neuronal degeneration and necrosis), bar 50 µm.
2.2. Immunohistochemsitry (IHC)
Two protocols with different antibodies were used for BoAstV-CH13/NeuroS1 de-
tection (Figure 2). The production of hyperimmune sera for each protocol are described
in detail elsewhere [8,22]. The first protocol was conducted with the polyclonal antibody
CH13-ORF2con, which is directed against the conserved N-terminal half of the capsid
precursor protein, encoded by ORF2 of BoAstV-CH13/NeuroS1 [22] (Figure 3a). Formalin-
fixed and paraffin embedded (FFPE) tissue samples of the brain (n = 5), spinal cord (n = 5),
heart (n = 1), liver (n = 1), uterus (n = 1), and kidney (n = 1) were first deparaffinized, rehy-
drated, and the endogenous peroxidase reactivity was blocked with a 3% H2O2 solution
diluted in methanol. Tissue sections were microwaved in Dako Target Retrieval Solution,
pH 9 (Agilent, Santa Clara, California, USA). Subsequent protein blocking was performed
by using 10% goat serum in phosphate-buffer saline with 0.5% Tween (PBS-T). Each sam-
ple was then incubated with a 1:100 dilution of the primary CH13-ORF2con antibody
over night at 4 ◦C. Immunodetection was performed by using the Dako REAL Detection
System (Agilent) following the manufacturer’s instructions. The resulting staining was
assessed under a light microscope. In the second protocol, the polyclonal antibody CH13-
23917 was used, which was generated against a synthetic peptide of the capsid protein of
BoAstV-CH13/NeuroS1 6 (Figure 3a). This immunohistochemistry (IHC) was performed
on a tissue section of the caudal cervical spinal cord, which had also been tested with
the CH13-ORF2con protocol. Apart from microwaving the tissue section in Dako Target
Retrieval Solution with pH 6 and an antibody dilution of 1:50 in PBS-T, the same workflow
as described above was used for the CH13-23917 protocol. To assess the validity of the
IHC, FFPE tissue slides that were tested positive or negative for BoAstV-CH13/NeuroS1
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in previous studies served as positive or negative controls, respectively, in every IHC
run [12,21,23]. For both IHC protocols, we additionally tested spinal cord and brain tissue
sections of a control alpaca, that had shown no neurological signs or histopathological
lesions. IHC for detection of rabies was also performed at the Division of Experimental
Clinical Research, Vetsuisse-Faculty, University of Bern. IHC for detection of the borna
antigen from the hippocampus was performed at the Institute of Veterinary Pathology,





Figure 2. (a–d): Detection of neurotropic astrovirus infection with immunohistochemistry (IHC) and
in-situ hybridization (ISH). (a–b): IHC for the capsid protein ORF2 of BoAstV-CH13/NeuroS1 of
the spinal ganglia (a) and the cerebral cortex (b) using the polyclonal antiserum ORF2-con. There is
strong red granular-like staining of neuronal cells and their extensions, which morphologically appear
to be neurons, bar 100 µm. (c): IHC for the capsid protein using the polyclonal antiserum CH13-
23917. There is multifocal immunolabelling of neuronal cells and their extensions, morphologically
compatible with neurons, cervical spinal cord, bar 200 µm. (d): ISH; The RNA probe is directed
against ORF2 of BoAstV-CH13/NeuroS1. There is massive intracytoplasmic red granular staining
of neuronal cells and their extensions, morphologically compatible with neurons, hippocampus,
bar 100 µm.
2.3. Real-Time RT-PCR (RT-qPCR)
RNA was extracted from FFPE tissue of the thoracic spinal cord as described in detail
in a paper of Delnatte et al. [24]. Two 20 µm thick sections of FFPE were deparaffinized with
xylol and then further processed using the RNeasy FFPE kit (Qiagen, Hilden, Germany)
according to the manufacturer’s instructions. For detection and amplification of the RNA
extract, we used the recently developed quantitative fluorescent reporter-probe based real-
time RT-PCR protocol, which is described in detail in another study [23]. Three different
primer-probe combinations were used, targeting the following regions of the BoAstV-
CH13/NeuroS1 genome: the 5′end of ORF1a, the center of the genome at the ORF1b-ORF2
interception, and the 3′end of ORF2 (Figure 3a). The respective protocols were designated
RT-qPCR CH13-A, -B, and -C. All RT-qPCR reactions were performed by using the AgPath-
ID One-Step RT-PCR System (New England Biolabs, Ipswich, MA, USA) according to the
manufacturer’s instructions in MicroAmp Optical 96-well reaction plates (Life technologies,
Ipswich, MA, USA) in a 7300 Real-time PCR System (Applied Biosystems, Waltham, MA,
USA). Fluorescence was measured at the end of each elongation step with the FAM filter
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Figure 3. (a,b): Molecular diagnostic tools for the identification of Bovine Astrovirus CH13/NeuroS1
in the alpaca. (a): schematic drawing of the viral genome is presented. Red bars indicate target
regions of the BoAstV-CH13/NeuroS1 real-time RT-PCR-A, -B and -C, respectively. The binding
side of the RNA probe for in-situ hybridization (ISH) is indicated as a blue dashed line. Polyclonal
antibodies for immunohistochemistry were generated against a recombinant protein corresponding
to the conserved region (ORF2con) and a 14 amino-acid synthetic peptide (23917) of the capsid
protein, encoded by ORF2. (b): Results of next generation sequencing of an RNA extract from
formalin-fixed and paraffin embedded (FFPE) brain tissue of the affected alpaca. The graph shows
the coverage and read depths of the new Bovine Astrovirus CH13 strain along the viral genome.
2.4. Next Generation Sequencing (NGS)
RNA was extracted from FFPE tissue of the cranial thoracic spinal cord as described
above. Library preparation was done using the TruSeq Stranded Total RNA Kit (Illumina,
San Diego, California, USA). The library was quality controlled on a Fragment Analyzer
(Advanced Analytical Technologies, Ames, IA, USA) with the High Sensitivity NGS Frag-
ment Analysis Kit (Advanced Analytical Technologies). Next, the library was sequenced
on an Illumina NovaSeq 6000 generating 2 × 50 bp reads. Raw reads were quality checked
using fastqc (Ver. 0.11.7) and trimmed and filtered with fastp (Ver. 0.12.5, parameters: −l
33 −W 4 −M 15 −5 3 −3 3). The remaining reads were mapped against the host genome
(Vicugna_pacos-2.0.1, BioProject PRJNA30567) using STAR (Ver. 2.6.0c, default parameters).
Unmapped reads were then mapped to the BoAstV-CH13/NeuroS1 RefSeq entry (accession
number NC_024498.1) using bowtie2 (Ver. 2.3.4.1, default parameters). Geneious Prime
(Biomatters Ltd., Auckland, New Zealand, Ver. 2019.1.1) was used to create the coverage
plot.
2.5. In-Situ Hybridization (ISH)
Chromogenic ISH was performed using the RNAscope system (Advanced Cell Di-
agnostics, Newark, New Jersey, USA) with a BoAstV-CH13/NeuroS1 RNAscope probe
directed against ORF2 (Advanced Cell Diagnostics; Cat No. 406921) (Figure 3a). ISH was
performed on a FFPE tissue slide of the hippocampus. Staining was carried out with the
RNAscope 2.5 Detection Kit Red (Advanced Cell Diagnostics) according to the manufac-
turer’s instructions. The slide was counterstained in Mayer’s hemalum solution (Merck
KGaA, Darmstadt, Germany) and mounted with Aquatex® (Merck KGaA) mounting me-
dia. Positive and negative control samples, which were shown to be positive and negative,
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respectively, for BoAstV-CH13/NeuroS1 in previous studies, were tested at the same
time [12,22].
2.6. RNA Extraction from Specimen of Conspecifics
Feces, EDTA-blood and nasal swabs of all four remaining alpacas of the herd were
taken in August 2019 for RNA extraction. Fecal samples were mixed 1:10 (w/v) in PBS, vor-
texed vigorously and centrifuged for 20 min at 4000× g at 4 ◦C. The supernatant was used
for RNA extraction. Nasal swabs were transported in universal viral transport medium
(BD, Eysins, Switzerland), vortexed and RNA was extracted from the medium. RNA ex-
traction was performed with Trizol LS (Thermo Fisher, Basel, Switzerland) according to the
instructions of the provider.
3. Results
3.1. Gross and Histopathological Findings
On submission, the carcass was in a good nutritional condition. The abdominal cavity
contained about 200 mL of serosanguinous fluid (ascites). Both kidneys showed multiple
chronic infarcts radiating from the surface to the medulla. The remaining thoracic and
abdominal organs were macroscopically within normal limits. Meninges of brain and
spinal cord were multifocally congested, but otherwise unremarkable. No evidence of a
space occupying mass, as previously suspected, was observed.
On histology, the main lesions were identified within the CNS. Affecting the grey
matter of the brain and spinal cord, and also affecting the spinal ganglia, there was a
severe inflammatory process, characterized by prominent lymphohistiocytic perivascular
cuffs, multifocal degenerated and necrotic neurons, and prominent glial nodules (Figure 1).
Within the spinal cord, lymphoplasmacytic infiltrates coalesced, and axons showed degen-
eration and necrosis characterized by swelling of axons and axon sheaths, axonophagia,
and the presence of gitter cells. The most prominent lesions were observed in the caudocer-
vical and thoracic spinal cord. The craniocervical and lumbosacral spinal cord segments
were moderately, thalamus, brainstem, and cortex mildly affected by the inflammatory
process. Within the liver, hepatocytes diffusely showed mild vacuolization of cytoplasm,
interpreted as mild hepatic steatosis. Tissue sections of heart, kidney, and uterus were
histologically unremarkable, except for the chronic kidney infarcts. These findings led to
the morphologic diagnosis of a chronic, lymphohistiocytic polioencephalomyelitis and
ganglioneuritis with gliosis and neuronal necrosis. Based on these lesions, a viral agent
was considered the most likely cause of disease.
3.2. Results from IHC, ISH, RT-PCR, and NGS
The IHC using the ORF2-con antiserum against BoAstV-CH13/NeuroS1 and the
polyclonal antibody CH13-23917 resulted in abundant positive immunostaining within
all examined tissue sections of the brain and spinal cord (Figure 2a–c). The positive sig-
nal consisted of red granular deposits, mostly within the cytoplasm of cells, which were
morphologically compatible with neurons. The localization of positive labelling was in
accordance with inflammatory lesions. The IHC of kidney, heart, liver, and uterus remained
negative. The validity of each IHC protocol was checked with a negative and positive
control sample. In every series of IHC, the positive control showed appropriate immunos-
taining, whereas the negative control remained negative. Brain and peripheral organ
tissue samples from the control alpaca also remained negative. The IHC for detection of
rabies and borna antigen remained negative. In conclusion, we considered the alpaca to be
immunopositive for both BoAstV-CH13/NeuroS1-ORF2con and BoAstV-CH13/NeuroS1-
23917 IHC.
In order to visualize the presence of viral RNA in situ, ISH of the hippocampus was
performed. Positive signal consisted of red granular deposits. The probe targeting the ORF2
of BoAstV-CH13/NeuroS1 (Figure 3a) abundantly labelled the cytoplasm of cells with the
morphology of neurons (Figure 2d), confirming the presence of BoAstV-CH13/NeuroS1
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RNA. Positive control FFPE tissue slides scored simultaneously positive, while positive
labelling was absent in negative control slides.
Three months after taking tissue samples at necropsy, RNA extract from FFPE tissue
of the thoracic spinal cord was tested by three different BoAstV-CH13/NeuroS1 specific
real-time RT-PCR protocols (RT-qPCR CH13-A, -B and -C) targeting different regions of
the viral genome (Figure 3a). While the protocols A and B were negative, protocol C,
which targets the 3′ end of ORF2, was positive with a Cq of 30. In contrast, the analysis of
fecal and nasal swabs and blood samples from the animal’s herd members were negative
when tested for astroviruses by real-time RT-PCR.
To further assess the genomic sequence of the detected virus, NGS of total RNA was
performed. In total 14′346′488 reads were generated. After quality trimming and filtering,
mapping resulted in 496 BoAstV-CH13/NeuroS1 reads covering 83.4% of the BoAstV-
CH13/NeuroS1 genome (Figure 3b), with a pairwise identity of 98.9%. In conclusion,
the discovered virus is almost identical to BoAstV-CH13/NeuroS1. No other pathological
viruses were detected in NGS.
4. Discussion
Over the last few years, reports of astrovirus-associated neurological diseases have
increased in many species all over the world [5–23,25]. One of these reported astroviruses
is BoAstV-CH13/NeuroS1, which has been frequently identified in cattle in Switzerland
suffering from viral encephalitis and is therefore considered an important etiological agent
in this species [11,13,14,26]. To our knowledge, BoAstV-CH13/NeuroS1 has not been
detected in other animals, and to this day, no astrovirus-infections have been reported in
alpacas.
In the present case, an alpaca with progressive neurological signs was euthanized and
submitted to our pathology service for further investigation of its illness. Histopathology
of the spinal cord and brain revealed a non-suppurative polioencephalomyelitis with neu-
ronal necrosis and gliosis, and a viral etiology was considered to be most likely the cause
of disease. Rabies and borna disease are among possible viral agents for non-suppurative
encephalitis in alpacas, and were first ruled out by IHC [27–29]. When performing IHC
on the brain and spinal cord against two different epitopes of BoAstV-CH13/NeuroS1,
cells morphologically compatible with neurons were distinctly stained, demonstrating the
presence of a virus with similar or identical antigenetic structure to BoAstV-CH13/NeuroS1.
Mostly, immunolabelling occurred within areas of pronounced inflammation, supporting a
causal link of virus with the disease. However, there was also an absence of immunolabel-
ing in inflamed areas, which could be explained by a potential clearance of the virus in the
immune reaction response. Within peripheral organs, no significant histological lesions
caused by a viral agent nor immunolabeling by IHC were present, further supporting
a particular neurotropism of this virus. The presence of lesions and viral antigen in the
spinal ganglia support the notion of neuroinvasion by axonal spread from the periphery,
presumably from the gastro-intestinal tract, rather than by systemic infection and/or by
the hematogenous route.
Additionally, the ISH on FFPE of the hippocampus with an RNA probe directed against
ORF2 of BoAstV-CH13/NeuroS1 confirmed our findings from IHC. The real-time RT-PCR
from FFPE tissue of the spinal cord was only positive for the primer-probe combination
targeting the 3′end of ORF2, while the other two primer-probe combinations (against the
5′end of ORF1a and the center of the genome at the ORF1b-ORF2 interception) remained
negative. The Cq value of 30 for the protocol targeting the 3′end of ORF2 is high, which
contradicted our findings from IHC and ISH, in which we clearly demonstrated abundant
presence of viral antigen and RNA by targeting this antigenetic region. When mapping
reads from NGS on the RNA extract of FFPE tissue against the BoAstV-CH13/NeuroS1
genome, they resulted in coverage of 83.4% of the BoAstV-CH13/NeuroS1 genome with a
pairwise identity of 98.9% and demonstrated that the detected virus is almost identical to
BoAstV-CH13/NeuroS1. Subsequent analysis of NGS data revealed that binding regions
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for both, primer and probe for all three real-time RT-PCR protocols, were present within
the extracted virus. Even though the amplicons used in each protocol were short, solid
results are only provided when the target regions are not fragmented. Therefore, the most
likely explanation for the negative results of protocols A and B in the real-time RT-PCR
is cross-linking and fragmentation of the RNA in the FFPE tissue of the spinal cord due
to exposure to formalin, which can cause RNA extracts to be difficult targets for nucleic
acids-based assays [30]. The successful outcome of NGS was likely positively influenced by
using reads of short length (50 bp), which were utilized in order to also catch fragmented
RNA sequences.
By using different diagnostic approaches, we were able to demonstrate that a virus
almost identical to BoAstV-CH13/NeuroS1 was associated with polioencephalomyelitis in
an alpaca, which, to this day, is the first report of such an infection in a camelid. The high ge-
nomic similarity emphasizes the possibility of an inter-species transmission of neurotropic
astroviruses, which has already been postulated for other species [15,16,21]. In the last
couple of years, it has been brought to light that cases of neurotropic astrovirus infections
involve a variety of different animal species and humans, and investigation into the patho-
logical mechanisms driving disease is a major issue in astrovirus research [1,7–11,15–18].
Recent preliminary studies on human astroviruses were able to culture human astroviruses
within astrocytes in vitro, which is integral in the understanding of astrovirus neuropatho-
genesis. The production of inflammatory cytokines, as well as the abortive effects of human
astroviruses to different neuronal cells, was also demonstrated in this study [31]. However,
to this day, apart from immunosuppression, which seems to play an important role in
humans, little is known about the factors contributing to the neuroinvasion of astroviruses
in other species [1,2,9,17]. Whether the alpaca had suffered from an immunosuppressive
condition or disease at some point in life is unknown. Based on our information, the re-
maining alpacas of the herd are healthy. In cattle, BoAstV-CH13/NeuroS1 was found in
fecal samples of clinically healthy animals, suggesting that this virus primarily infects the
gastrointestinal tract and that subclinical infected animals serve as a virus reservoir [32].
However, additional retrospective analysis of fecal and nasal swabs as well as blood sam-
ples from these alpacas were negative when tested for BoAstV-CH13/NeuroS1 by RT-PCR
and to our knowledge, the animal had not been in close contact with cattle or other domes-
tic animals. Ultimately, we were not able to find the source of infection for this particular
animal.
Several recent metagenomic studies have identified a huge number of novel astro-
virus candidates in mammalian and non-mammalian species. These include rodents, fish,
amphibians, reptiles, and insects, suggesting that that the diversity and host range of
Astroviridae still remains largely unexplored [33–36]. These hosts species sometimes live in
close proximity to humans and livestock and the interspecies jumping of these agents may
cause a threat to human and animal health [33]. To assess and predict the zoonotic potential
of astrovirus infections, we need a better understanding of infection dynamics, including
the shedding and transmission of viruses within and between species. Novel sequencing
techniques and bioinformatics workflows are powerful tools to gain more detailed data on
phylogenetic relationships of astroviruses from camelids, cattle, humans, and other hosts.
5. Conclusions
Our findings demonstrate that neurotropic astroviruses have to be included in differ-
ential diagnosis for neurologic diseases in alpacas. Furthermore, we were able to show
the close genetic relationship of the detected virus and BoAstV-CH13/NeuroS1 by NGS.
These results suggest that BoAstV-CH13/NeuroS1 is not host specific, which has already
been postulated for other viruses of this family and can cross the species barrier. Further
research should aim to investigate the pathogenesis of this infection and identify factors,
which contribute to neuroinvasion and mechanisms of species crossing.
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